Novel Agents and Strategies in Lung Cancer
Oncology Today with Dr Neil Love
00:00
Telemedicine and TDXD: Innovations in Lung Cancer Treatment
This chapter explores the intersection of telemedicine and clinical research in oncology, particularly influenced by the COVID-19 pandemic. It highlights the new approval of TDXD for lung cancer and emphasizes the significance of HER2 testing in treatment strategies. The conversation also addresses the management of side effects and premedication protocols, providing insights into evolving practices among oncologists.
Transcript
Play full episode
